Brawn Biotech share news, announcements and annual reports
BSE: 530207Pharmaceuticals & BiotechnologySmall Cap
Brawn Biotech Limited · Face value ₹10 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed May 1995
Last close ₹24.61down ₹1.26 (4.87%)
Share price at the BSE close on 30 Oct 2026. Previous close ₹25.87.
30 Oct: open ₹25.75, high ₹25.75, low ₹24.61
52-week range of traded prices to 30 Oct 2026
₹17.71Low, 16 Feb 2026₹26.64High, 28 Oct 2026
- Next results date: the board meets on 5 Nov 2026 to consider: quarterly results. Results calendar
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹7.38 Cr4,925th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- 8.60
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- 1.70
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it.
- 22.3%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet.
- −12.6%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026.
- 0.00
- Volume, BSEVolume. Shares traded on the last trading day. Volume in the glossary
- 100
Brawn Biotech board meetings
103 filed, newest first. Page 2 of 3.
May 2022
19 May · Board meeting
Meeting on 25 May 2022: audited results
Feb 2022
7 Feb · Board meeting
Meeting on 12 Feb 2022: quarterly results
Nov 2021
2 Nov · Board meeting
Meeting on 10 Nov 2021: quarterly results
Aug 2021
6 Aug · Board meeting
Meeting on 12 Aug 2021: quarterly results and annual general meeting
May 2021
27 May · Board meeting
Meeting on 4 Jun 2021: audited results
Mar 2021
22 Mar · Board meeting
Meeting on 24 Mar 2021
Feb 2021
2 Feb · Board meeting
Meeting on 12 Feb 2021: quarterly results
Nov 2020
10 Nov · Board meeting
2 Nov · Board meeting
Meeting on 10 Nov 2020: quarterly results
Aug 2020
13 Aug · Board meeting
Meeting on 21 Aug 2020: annual general meeting and quarterly results
Jun 2020
9 Jun · Board meeting
Meeting on 18 Jun 2020: audited results
Jan 2020
31 Jan · Board meeting
Meeting on 11 Feb 2020: quarterly results
Nov 2019
4 Nov · Board meeting
Meeting on 12 Nov 2019: quarterly results
Aug 2019
5 Aug · Board meeting
Meeting on 13 Aug 2019: quarterly results
May 2019
14 May · Board meeting
Meeting on 22 May 2019: audited results
Apr 2019
24 Apr · Board meeting
Meeting on 25 Apr 2019
Feb 2019
4 Feb · Board meeting
Meeting on 11 Feb 2019: quarterly results
Jan 2019
28 Jan · Board meeting
Meeting on 28 Jan 2019
Nov 2018
Oct 2018
Aug 2018
Feb 2018
12 Feb · Board meeting
Oct 2017
Aug 2017
Apr 2017
Feb 2017
22 Feb · Board meeting
Aug 2016